BioSpace News Archive

The Award was presented to Dr. Jhoti by BIA Chair, Dr. Jane Osbourn.

The international Cell & Gene Therapy World conference gather nearly 1,300 industry professionals from more than 30 countries.

Saniona and Proximagen entered into this drug discovery and development collaboration in the beginning of 2016.

The CHMP concluded that an approval for Raxone in DMD, applied as a Type II variation of the existing marketing authorization, cannot be granted at the present time based on the current existing evidence

The Company identifies and implements plan to improve its recombinant spider silk.

The total net proceeds of the offering are approximately $5.9 million after deducting the underwriting discounts and commissions payable by Histogenics.

The addition of a senior executive of Tim’s caliber is another proof point as we advance our strategy to meet U.S. demand

The multi-center, single arm study intends to enroll 200 subjects with deep venous disease from up to 35 sites throughout the U.S. and Europe.

Verastem today announced that a poster highlighting the synergistic effects of duvelisib in combination with immune checkpoint or co-stimulatory antibodies in preclinical models of B cell lymphoma was presented at ASCO-SITC Clinical Immuno-Oncology Symposium being held January 25-27, 2018 in San Francisco.

CanniMed Therapeutics Inc .announces that it plans to release its financial results for the year ended October 31, 2017 after close of markets on Monday, January 29, 2018.